(Q32088604)
Statements
1 reference
Rosiglitazone monotherapy is effective in patients with type 2 diabetes (English)
1 reference
H E Lebovitz
1 reference
J F Dole
1 reference
R Patwardhan
1 reference
E B Rappaport
1 reference
M I Freed
1 reference
Rosiglitazone Clinical Trials Study Group
1 reference
1 January 2001
1 reference
280-288
1 reference
Identifiers
1 reference
1 reference